Identification of 4-(6-((2-methoxyphenyl)amino)pyrazin-2-yl)benzoic acids as CSNK2A inhibitors with antiviral activity and improved selectivity over PIM3

被引：1

作者：

Galal, Kareem A. ^{[1
,2
]}

Kraemer, Andreas ^{[3
,4
,5
]}

Strickland, Benjamin G. ^{[1
]}

Smith, Jeffery L. ^{[1
]}

Dickmander, Rebekah J. ^{[2
,6
,7
,8
]}

Moorman, Nathaniel J. ^{[2
,6
,7
]}

Willson, Timothy M. ^{[1
,2
]}

机构：

[1] Univ North Carolina Chapel Hill, UNC Eshelman Sch Pharm, Struct Genom Consortium, Chapel Hill, NC 27599 USA

[2] Rapidly Emerging Antiviral Drug Dev Initiat READDI, Chapel Hill, NC 27599 USA

[3] Goethe Univ Frankfurt, Buchmann Inst Life Sci, Struct Genom Consortium, Max Von Laue Strabe 15, D-60438 Frankfurt, Germany

[4] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max Von Laue Strabe 9, D-60438 Frankfurt, Germany

[5] Frankfurt Canc Inst, Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany

[6] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA

[7] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

[8] Univ North Carolina Chapel Hill, Dept Chem, Chapel Hill, NC 27599 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2024年 / 99卷

关键词：

A B S T R A C T; 2,6-DISUBSTITUTED PYRAZINES; KINASES; CK2;

D O I：

10.1016/j.bmcl.2024.129617

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We report the synthesis of 2,6-disubstituted pyrazines as potent cell active CSNK2A inhibitors. 4 '-Carboxyphenyl '-Carboxyphenyl was found to be the optimal 2-pyrazine substituent for CSNK2A activity, with little tolerance for additional modification. At the 6-position, modifications of the 6-isopropylaminoindazole substituent were explored to improve selectivity over PIM3 while maintaining potent CSNK2A inhibition. The 6-isopropoxyindole analogue 6c was identified as a nanomolar CSNK2A inhibitor with 30-fold selectivity over PIM3 in cells. Replacement of the 6-isopropoxyindole by isosteric ortho-methoxy anilines, such as 7c , generated analogues with selectivity for CSNK2A over PIM3 and improved the kinome-wide selectivity. The optimized 2,6-disubstituted pyrazines showed inhibition of viral replication consistent with their CSNK2A activity.

引用

页数：6

共 50 条

[31] SYNTHESIS OF SOME NEW 2-(4-METHOXYBENZOTHIAZOL-2′-YL AMINO)-4-(2-CHLORO-4-TRIFLUOROMETHYLANILINO)-6-(SUBSTITUTED THIOUREIDO)-1,3,5-TRIAZINE AS ANTIFUNGAL AGENTS
Sareen, Vineeta
Khatri, Vineeta
Jain, Prakash
Sharma, Kanti
PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 2010, 185 (01) : 140 - 146
[32] CRYSTAL STRUCTURE AND DFT STUDIES OF 4-(1-BENZYL-5-METHYL-1H-1,2,3-TRIAZOL-4-YL)-6-(3-METHOXYPHENYL)PYRIMIDIN-2-AMINE
Murugavel, S.
Vijayakumar, S.
Nagarajan, Sangaraiah
Ponnuswamy, Alagusundaram
JOURNAL OF THE CHILEAN CHEMICAL SOCIETY, 2014, 59 (04): : 2640 - 2646
[33] Crystal structure of 1-[2-[6-(4-methoxyphenyl)-3(2H)-pyridazinone-2-yl]acetyl]-4-(3-chlorophenyl)piperazine, C23H23ClN4O3
Ingeç, SK
Soylu, H
Engin, K
Dogruer, DS
Sahin, MF
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2000, 215 (03): : 433 - 434
[34] Identification of Structural Features for 4-Methyl-3-(6-[Phenyl Methylene] Amino} Pyridine-3-yl)-2h Chromen-2-One Derivatives as Clotting Factor XA Inhibitors
Ingale, Kundan B.
Bhatia, Manish S.
MEDICINAL CHEMISTRY, 2012, 8 (02) : 299 - 307
[35] Synthesis, characterization and antimicrobial activity of some novel 4-(4-(arylamino)-6-(piperidin-1-yl)-1,3,5-triazine-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamides
Desai, N. C.
Makwana, Atul H.
Senta, R. D.
JOURNAL OF SAUDI CHEMICAL SOCIETY, 2016, 20 (06) : 686 - 694
[36] Pharmacological characterization of a novel potent, selective, and orally active phosphodiesterase 10A inhibitor, PDM-042 [(E)-4-(2-(2-(5,8-dimethyl-[1,2,4] triazolo [1,5-a] pyrazin-2-yl) vinyl)-6-(pyrrolidin-1-yl) pyrimidin-4-yl) morpholine] in rats: potential for the treatment of schizophrenia
Arakawa, Keita
Maehara, Shunsuke
Yuge, Natsuko
Ishikawa, Makoto
Miyazaki, Yutaka
Naba, Hiroyasu
Kato, Yutaka
Nakao, Kazunari
PHARMACOLOGY RESEARCH & PERSPECTIVES, 2016, 4 (04):
[37] (3R)-3-amino-4-(2,4,5-trigluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamideas a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Nitta, Aiko
Fujii, Hideaki
Sakami, Satoshi
Nishimura, Yutaka
Ohyama, Tomofumi
Satoh, Mikiya
Nakaki, Junko
Satoh, Shiho
Inada, Chifumi
Kozono, Hideki
Kumagai, Hiroki
Shimamura, Masahiro
Fukazawa, Tominaga
Kawai, Hideki
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5435 - 5438
[38] Synthesis and antiviral activity of new 4-(phenylamino)/4-[(methylpyridin-2-yl)amino]-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acids derivatives
Alice Maria Rolim Bernardino
Alexandre Reis de Azevedo
Luiz Carlos da Silva Pinheiro
Júlio Cesar Borges
Vinícius Lucio Carvalho
Milene Dias Miranda
Marcelo Damião Ferreira de Meneses
Marcelo Nascimento
Davis Ferreira
Moacyr Alcoforado Rebello
Viveca Antonia Giongo Galvão da Silva
Izabel Christina Palmer Paixão de Frugulhetti
Medicinal Chemistry Research, 2007, 16 : 352 - 369
[39] Synthesis and antiviral activity of new 4-(phenylamino)/4-[(methylpyridin-2-yl)amino]-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acids derivatives
Rolim Bernardino, Alice Maria
Reis de Azevedo, Alexandre
da Silva Pinheiro, Luiz Carlos
Cesar Borges, Julio
Lucio Carvalho, Vinicius
Dias Miranda, Milene
Ferreira de Meneses, Marcelo Damiao
Nascimento, Marcelo
Ferreira, Davis
Alcoforado Rebello, Moacyr
Giongo Galvao da Silva, Viveca Antonia
de Frugulhetti, Izabel Christina Palmer Paixao
MEDICINAL CHEMISTRY RESEARCH, 2007, 16 (7-9) : 352 - 369
[40] SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF 6-[(E)-2-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)ETHEN-1-YL] AND 6-(1,2,3,4-TETRAHYDRO-1,1,4,4-TETRAMETHYL-6-NAPHTHYL)-2-NAPHTHALENECARBOXYLIC ACIDS
DAWSON, MI
CHAN, RLS
DERDZINSKI, K
HOBBS, PD
CHAO, WR
SCHIFF, LJ
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (11) : 1653 - 1656

← 1 2 3 4 5 →